MC
Matthew Caufield HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Kodiak Sciences
KOD
$452M
| $8.55 | $5 |
42%
downside
| Neutral | 17 days ago |
|
2
DiaMedica Therapeutics
DMAC
$278M
| $5.37 | $12 |
123%
upside
| Buy | 20 days ago |
|
3
Mineralys Therapeutics
MLYS
$2.2B
| $33.12 | $42 |
27%
upside
| Buy | 22 days ago |
|
|
LENZ
4
LENZ Therapeutics
LENZ
$1.14B
| $39.92 | $56 |
40%
upside
| Buy | 1 month ago |
|
5
Ardelyx
ARDX
$1.58B
| $6.57 | $10 |
52%
upside
| Buy | 2 months ago |
|
6
Phathom Pharmaceuticals
PHAT
$851M
| $12 | $20 |
67%
upside
| Buy | 2 months ago |
|
7
Akebia Therapeutics
AKBA
$801M
| $3.02 | $8 |
165%
upside
| Buy | 3 months ago |
|
8
Tarsus Pharmaceuticals
TARS
$2.42B
| $57.43 | $72 |
25%
upside
| Buy | 3 months ago |
|
9
Aldeyra Therapeutics
ALDX
$332M
| $5.53 | $10 |
81%
upside
| Buy | 3 months ago |
|
|
ZBIO
10
Zenas BioPharma, Inc. Common Stock
ZBIO
$715M
| $16.98 | $30 |
77%
upside
| Buy | 3 months ago |
|
11
4D Molecular Therapeutics
FDMT
$309M
| $6.61 | $36 |
445%
upside
| Buy | 6 months ago |
|
12
Fabrinet
FN
$12.9B
| $362.16 | $28 |
92%
downside
| Buy | 2 years ago |
|